Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Nelson

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cancer Biology & Therapy|March 28, 2007
Inhibition of lipoxygenase activity: implications for the treatment and chemoprevention of prostate cancerMark A Nelson
The Biochemical Journal|September 4, 2004
Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90Monika Mikolajczyk, Mark A Nelson
Biochemical and Biophysical Research Communications|July 26, 2005
The cyclin-dependent kinase 11 interacts with NOT2Jiaqi Shi, Mark A Nelson
Cancer Biology & Therapy|January 17, 2004
Glioma growth inhibition by selective COX-2 inhibitors via cyclooxygenase independent pathways: implications for therapyDurga P Cherukuri, Mark A Nelson
Cancer Biology & Therapy|October 14, 2005
Could the combination of celecoxib and 4HPR be an effective lung cancer treatment?Durga P Cherukuri, Mark A Nelson
Cancer Biology & Therapy|April 19, 2008
Role of reactive oxygen species (ROS) and JNKs in selenite-induced apoptosis in HepG2 cellsDurga P Cherukuri, Mark A Nelson
Cancer Biology & Therapy|October 7, 2004
Do elevated levels of eicosanoids play a role in head and neck cancer recurrence and metastasis? Implications for prevention and treatmentDurga P Cherukuri, Mark A Nelson
Gene|January 20, 2005
Isolation and characterization of the human Cdc2L1 gene promoterAmber Kahle, Yongmei Feng, Mark A Nelson
Gene|April 17, 2004
Identification and characterization of the human Cdc2l2 gene promoterYongmei Feng, Anne-Christine Goulet, Mark A Nelson
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Positional approaches to cancer geneticsGavin P Robertson, Linda Sargent, Mark A Nelson
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cancer Biology & Therapy|March 28, 2007
Inhibition of lipoxygenase activity: implications for the treatment and chemoprevention of prostate cancerMark A Nelson
The Biochemical Journal|September 4, 2004
Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90Monika Mikolajczyk, Mark A Nelson
Biochemical and Biophysical Research Communications|July 26, 2005
The cyclin-dependent kinase 11 interacts with NOT2Jiaqi Shi, Mark A Nelson
Cancer Biology & Therapy|January 17, 2004
Glioma growth inhibition by selective COX-2 inhibitors via cyclooxygenase independent pathways: implications for therapyDurga P Cherukuri, Mark A Nelson
Cancer Biology & Therapy|October 14, 2005
Could the combination of celecoxib and 4HPR be an effective lung cancer treatment?Durga P Cherukuri, Mark A Nelson
Cancer Biology & Therapy|April 19, 2008
Role of reactive oxygen species (ROS) and JNKs in selenite-induced apoptosis in HepG2 cellsDurga P Cherukuri, Mark A Nelson
Cancer Biology & Therapy|October 7, 2004
Do elevated levels of eicosanoids play a role in head and neck cancer recurrence and metastasis? Implications for prevention and treatmentDurga P Cherukuri, Mark A Nelson
Gene|January 20, 2005
Isolation and characterization of the human Cdc2L1 gene promoterAmber Kahle, Yongmei Feng, Mark A Nelson
Gene|April 17, 2004
Identification and characterization of the human Cdc2l2 gene promoterYongmei Feng, Anne-Christine Goulet, Mark A Nelson
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Positional approaches to cancer geneticsGavin P Robertson, Linda Sargent, Mark A Nelson
Pageof 6